Page 22 - AN-3-3

Advanced Neurology Alzheimer’s and Parkinson’s disease rodent models

doi: 10.1002/mds.23637 doi: 10.1016/j.neuron.2010.04.034
58. Dehay B, Bourdenx M, Gorry P, et al. Targeting α-synuclein for 69. Perez FA, Palmiter RD. Parkin-deficient mice are not
treatment of Parkinson’s disease: Mechanistic and therapeutic a robust model of parkinsonism. Proc Natl Acad Sci.
considerations. Lancet Neurol. 2015;14(8):855-866. 2005;102(6):2174-2179.
doi: 10.1016/S1474-4422(15)00006-X doi: 10.1073/pnas.0409598102
59. Chesselet MF, Fleming S, Mortazavi F, Meurers B. 70. Paul S, Pickrell AM. Hidden phenotypes of PINK1/
Strengths and limitations of genetic mouse models Parkin knockout mice. Biochim Biophys Acta Gen Subj.
of Parkinson’s disease. Parkinsonism Relat Disord. 2021;1865(6):129871.
2008;14 Suppl 2(Suppl 2):S84-S87.
doi: 10.1016/j.bbagen.2021.129871
doi: 10.1016/j.parkreldis.2008.04.004
71. Kitada T, Tong Y, Gautier CA, Shen J. Absence of nigral
60. Blesa J, Przedborski S. Parkinson’s disease: Animal models degeneration in aged parkin/DJ‐1/PINK1 triple knockout
and dopaminergic cell vulnerability. Front Neuroanat. mice. J Neurochem. 2009;111(3):696-702.
2014;8:155.
doi: 10.1111/j.1471-4159.2009.06350.x
doi: 10.3389/fnana.2014.00155
72. Noda S, Sato S, Fukuda T, et al. Loss of Parkin contributes to
61. Lin X, Parisiadou L, Sgobio C, et al. Conditional expression mitochondrial turnover and dopaminergic neuronal loss in
of Parkinson’s disease-related mutant α-synuclein in aged mice. Neurobiol Dis. 2020;136:104717.
the midbrain dopaminergic neurons causes progressive
neurodegeneration and degradation of transcription factor doi: 10.1016/j.nbd.2019.104717
nuclear receptor related 1. J Neurosci. 2012;32(27):9248-9264. 73. Wallings R, Manzoni C, Bandopadhyay R. Cellular processes
doi: 10.1523/JNEUROSCI.1731-12.2012 associated with LRRK2 function and dysfunction. FEBS J.
2015;282(15):2806-2826.
62. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin
gene cause autosomal recessive juvenile parkinsonism. doi: 10.1111/febs.13305
Nature. 1998;392(6676):605-608. 74. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2
doi: 10.1038/33416 cause autosomal-dominant parkinsonism with pleomorphic
pathology. Neuron. 2004;44(4):601-607.
63. Zhang Y, Gao J, Chung KK, Huang H, Dawson VL,
Dawson TM. Parkin functions as an E2-dependent doi: 10.1016/j.neuron.2004.11.005
ubiquitin- protein ligase and promotes the degradation of 75. Volta M, Melrose H. LRRK2 mouse models: Dissecting the
the synaptic vesicle-associated protein, CDCrel-1. Proc Natl behavior, striatal neurochemistry and neurophysiology of
Acad Sci U S A. 2000;97(24):13354-13359. PD pathogenesis. Biochem Soc Trans. 2017;45(1):113-122.
doi: 10.1073/pnas.240347797 doi: 10.1042/BST20160238
64. Dawson TM, Dawson VL. The role of parkin in 76. Lee Y, Dawson VL, Dawson TM. Animal models of
familial and sporadic Parkinson’s disease. Mov Disord. Parkinson’s disease: Vertebrate genetics. Cold Spring Harb
2010;25 Suppl 1(1):S32-S39. Perspect Med. 2012;2(10):a009324.
doi: 10.1002/mds.22798 doi: 10.1101/cshperspect.a009324
65. Kin K, Yasuhara T, Kameda M, Date I. Animal models for 77. Dovonou A, Bolduc C, Soto Linan V, Gora C, Peralta Iii MR,
Parkinson’s disease research: Trends in the 2000s. Int J Mol Lévesque M. Animal models of Parkinson’s disease: Bridging
Sci. 2019;20(21):5402. the gap between disease hallmarks and research questions.
doi: 10.3390/ijms20215402 Transl Neurodegener. 2023;12(1):36.
66. Narendra DP, Jin SM, Tanaka A, et al. PINK1 is selectively doi: 10.1186/s40035-023-00368-8
stabilized on impaired mitochondria to activate Parkin. 78. Ramonet D, Daher JPL, Lin BM, et al. Dopaminergic
PLoS Biol. 2010;8(1):e1000298. neuronal loss, reduced neurite complexity and autophagic
doi: 10.1371/journal.pbio.1000298 abnormalities in transgenic mice expressing G2019S mutant
LRRK2. PLoS One. 2011;6(4):e18568.
67. Schneider SA, Alcalay RN. Neuropathology of genetic
synucleinopathies with parkinsonism: Review of the doi: 10.1371/journal.pone.0018568
literature. Mov Disord. 2017;32(11):1504-1523. 79. Chasseigneaux S, Allinquant B. Functions of Aβ, sAPPα
doi: 10.1002/mds.27193 and sAPPβ : Similarities and differences. J Neurochem.
2012;120(s1):99-108.
68. Dawson TM, Ko HS, Dawson VL. Genetic animal models of
Parkinson’s disease. Neuron. 2010;66(5):646-661. doi: 10.1111/j.1471-4159.2011.07584.x

Volume 3 Issue 3 (2024) 16 doi: 10.36922/an.2903